Results
1 -
10 of
102Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus, Diabetes Therapy Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials, Advances in Therapy Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin, Advances in Therapy Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors, Clinical Pharmacokinetics The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups, Advances in Therapy Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials, European Journal of Clinical Pharmacology Drei Jahre Nutzenbewertung von neuen Arzneimitteln gem???? AMNOG, Arzneiverordnungs- Report 2014 Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment, Diabetes Therapy A Statistical Analysis of the Treatment of??Type 2 Diabetes in the Presence of Chronic Kidney Disease in Patients Hospitalized for??Heart Failure, The Mathematics of the Uncertain